CELLAGEN Trademark

Trademark Overview

On Tuesday, June 9, 1998, a trademark application was filed for CELLAGEN with the United States Patent and Trademark Office. The USPTO has given the CELLAGEN trademark a serial number of 75498409. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 24, 2013. This trademark is owned by GeriGene Medical Corporation. The CELLAGEN trademark is filed in the Chemical Products category with the following description:

CELLS GROWN IN CULTURE FOR SUBSEQUENT IMPLANTATION, NAMELY, FIBROBLASTS, EPITHELIAL CELLS, ENDOTHELIAL CELLS AND ADIPOCYTES

General Information

Serial Number75498409
Word MarkCELLAGEN
Filing DateTuesday, June 9, 1998
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 24, 2013
Registration Number2639960
Registration DateTuesday, October 22, 2002
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 11, 1999

Trademark Statements

Goods and ServicesCELLS GROWN IN CULTURE FOR SUBSEQUENT IMPLANTATION, NAMELY, FIBROBLASTS, EPITHELIAL CELLS, ENDOTHELIAL CELLS AND ADIPOCYTES

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 24, 2013
Primary Code001
First Use Anywhere DateWednesday, February 17, 1999
First Use In Commerce DateMonday, July 10, 2000

Trademark Owner History

Party NameGeriGene Medical Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressElkhart Lake, WI 53020
Party NameGeriGene Medical Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMadison, WI 53711
Party NameGeriGene Medical Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMadison, WI 53711

Trademark Events

Event DateEvent Description
Friday, May 24, 2013CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Tuesday, January 6, 2009WITHDRAWAL OF ATTORNEY GRANTED
Tuesday, January 6, 2009TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Monday, November 10, 2008REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, October 27, 2008ASSIGNED TO PARALEGAL
Wednesday, October 22, 2008TEAS SECTION 8 & 15 RECEIVED
Thursday, October 2, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 2, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 8, 2008CASE FILE IN TICRS
Wednesday, October 29, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 22, 2002REGISTERED-PRINCIPAL REGISTER
Monday, August 12, 2002ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 7, 2002ASSIGNED TO EXAMINER
Monday, August 5, 2002STATEMENT OF USE PROCESSING COMPLETE
Saturday, August 3, 2002USE AMENDMENT FILED
Tuesday, February 19, 2002EXTENSION 5 GRANTED
Saturday, February 2, 2002EXTENSION 5 FILED
Monday, August 13, 2001EXTENSION 4 GRANTED
Wednesday, August 1, 2001EXTENSION 4 FILED
Wednesday, May 30, 2001EXTENSION 3 GRANTED
Friday, February 2, 2001EXTENSION 3 FILED
Thursday, August 3, 2000EXTENSION 2 GRANTED
Thursday, August 3, 2000EXTENSION 2 FILED
Thursday, February 3, 2000EXTENSION 1 GRANTED
Thursday, February 3, 2000EXTENSION 1 FILED
Friday, January 12, 2001PETITION TO REVIVE-GRANTED
Friday, June 16, 2000PETITION TO REVIVE-RECEIVED
Tuesday, April 11, 2000ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 3, 1999NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 11, 1999PUBLISHED FOR OPPOSITION
Friday, April 9, 1999NOTICE OF PUBLICATION
Thursday, February 25, 1999APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 16, 1999EXAMINER'S AMENDMENT MAILED
Thursday, February 11, 1999ASSIGNED TO EXAMINER

Related Keywords

cellagen cells epithelial endothelial adipocytes fibroblasts implantation grown culture subsequent namely